Arvinas Presents Data on its BET PROTAC Degraders at 2016 EORTC-NCI-AACR Symposium NEW HAVEN, Conn., November 29, 2016 – Arvinas LLC, a private biotechnology company creating a new class of drugs based on protein degradation, today announced that data were presented...
Intarcia Submits New Drug Application (NDA) to FDA for U.S. Marketing Approval of ITCA 650 in Type 2 Diabetes The NDA submission reflects more than 10 years of innovation and clinical development of ITCA 650 to respond to pressing unmet needs in type 2 diabetes. ITCA...
UAB Medicine Selects Kyruus for Patient-Provider Matching and Provider Data Management on Nov 14, 2016 12:54:00 PM BOSTON, MA – Kyruus, a leader in provider search and scheduling solutions for health systems, announced today that UAB Medicine, one of the top four...
Truveris Ranked Number 131 Fastest Growing Company in North America on Deloitte’s 2016 Technology Fast 500™ Nov 16, 2016 Truveris ranked 131 on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences...
Versartis Presents Safety, Efficacy and IGF-I Data for Somavaratan in Pediatric Growth Hormone Deficiency at the 2016 Congress of the GRS & IGF Society Increasing somavaratan dose to the 3.5mg/kg twice-monthly now used in Phase 3 safely improved IGF-I SDS and...
Recent Comments